Stock Screener App

Gratuito -

Installare

16.23

1.18% 0.19

Viatris Inc (VTRS)

Panoramica Notizia Cronologia dei prezzi Catena di opzioni Financials Forum Previsione Frazionamento azionario Storia dei dividendi

Viatris Inc Borsa (VTRS) Ultime notizie

5 Must-Read Analyst Questions From Viatris’s Q2 Earnings Call - Yahoo Finance

Viatris Inc. stock rises Friday, outperforms market - MarketWatch

Viatris Inc. (VTRS) Stock Price, News, Quote & History - Yahoo! Finance Canada

Viatris (VTRS) is Selling Tyrvaya, but Could Harrow (HROW) Turn it Into a Growth Engine? - Yahoo Finance

Viatris Inc. stock falls Wednesday, underperforms market - MarketWatch

Davis Selected Advisers (VTRS) discloses 75.2M-share, 6.5% stake in Viatris Inc - Stock Titan

ETFs Investing in Viatris, Inc. Stocks - TradingView

TBPH Meets Q2 Earnings Estimates, to be Acquired by Zymeworks - TradingView

Viatris (VTRS) Stock Trades At A Discount To Sales Despite A 76% Run - Sahm

Theravance Biopharma Q2 2026: Viatris collaboration revenue $20.7M; net loss $5.9M; $388M cash - TradingView

Why Viatris (VTRS) Is Down 6.4% After Boosting Guidance And Completing A $1.15 Billion Buyback - simplywall.st

Viatris (VTRS) Is Down 6.4% After Raising 2026 Guidance And Completing Major Buyback Program - Yahoo Finance

Viatris (VTRS) Stock May Be Below Fair Value Despite FDA Patch Approval - Yahoo Finance

Viatris (VTRS) Stock Sees Modest Fair Value Lift After Q1 Results And Pipeline Progress - Yahoo Finance

Viatris Inc. (VTRS) Stock Forecasts - Yahoo! Finance Canada

Viatris (VTRS) Stock Looks Stuck Between Higher Guidance And Wider Losses - Sahm

Viatris Inc. (US92556V1061.SG) Stock Price, News, Quote & History - Yahoo! Finance Canada

Viatris Inc. Stock Sheds 7.7%, Underperforms Market - webull.com

Viatris Earnings: Good Performance in Key Regions and Outlook Increase Make for a Solid Quarter - Morningstar

Harrow Enters Agreement to Acquire Tyrvaya Dry Eye Treatment From Viatris Inc. - VisionMonday.com

Viatris Inc. Stock 12‑Month Price Target Raised to $18.71, Implies 6% Upside - TradingView

Viatris Inc (VTRS) (Q2 2026) Earnings Call Highlights: Strong Growth and Raised Guidance Amid ... - Yahoo Finance

Viatris Inc (VTRS) Shares Fall 7.6% -- GF Value Says Still Overv - GuruFocus

Viatris Inc. stock falls Thursday, underperforms market - MarketWatch

Viatris Inc Q2 2026: Revenue $3.76B, EPS $(0.10) — 10-Q Summary - TradingView

Viatris (NASDAQ: VTRS) swings to H1 2026 profit as revenue tops $7.27B - Stock Titan

Tranche Update on Viatris Inc.'s Equity Buyback Plan announced on February 28, 2022. - marketscreener.com

Viatris Q2 2026 slides: strong beat, raised outlook, H2 headwinds - Investing.com

Viatris Q2 2026 slides: strong results lift guidance amid H2 headwinds - Investing.com

Viatris Sharpens Focus with Divestiture, Hikes 2026 Outlook - TradingView

Viatris Looks to New Launches, Pipeline Progression, and Cost Savings for Long-Term Growth - Morningstar

Viatris Inc. 2026 Q2ResultsEarnings Call Presentation (NASDAQ:VTRS) 2026-08-06 - Seeking Alpha

Viatris stock hits 52-week high at 18.27 USD - Investing.com

Viatris Q2 2026 slides: strong beat drives guidance raise - Investing.com

FMR LLC discloses 8.3% Viatris Inc (VTRS) ownership, over 96M shares - Stock Titan

Earnings call transcript: Viatris tops Q2 2026 estimates, lifts outlook - Investing.com

Viatris Announces Quarterly Dividend - marketscreener.com

Viatris Inc. reports results for the quarter ended June 30Earnings Summary - TradingView

Compared to Estimates, Viatris (VTRS) Q2 Earnings: A Look at Key Metrics - Yahoo Finance

Viatris Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 - marketscreener.com

VIATRIS INC (VTRS.VI) Q2 FY2026 earnings call transcript - Yahoo Finance

Viatris (VTRS) Beats Q2 Earnings and Revenue Estimates - Yahoo Finance

Viatris' Q2 Adjusted Earnings, Revenue Rise; Lifts 2026 Guidance - marketscreener.com

(VTRS) Viatris Expects 2026 Revenue Range $14.55B$14.95B, vs. FactSet Est of $14.79B - marketscreener.com

(VTRS) Viatris Expects 2026 Adjusted EPS Range $2.45$2.59, vs. FactSet Est of $2.45 - marketscreener.com

Viatris raises annual profit forecast on branded drug strength - marketscreener.com

Viatris (NASDAQ:VTRS) Posts Better-Than-Expected Sales In Q2 CY2026 - Yahoo Finance

Viatris posts Q2 beat; sells eye drug Tyrvaya to Harrow for up to $100M - Seeking Alpha

Earnings Flash (VTRS) Viatris Inc. Reports Q2 Revenue $3.76B, vs. FactSet Est of $3.68B - marketscreener.com

Earnings Flash (VTRS) Viatris Inc. Posts Q2 Adjusted EPS $0.69 per Share, vs. FactSet Est of $0.60 - marketscreener.com

Viatris: Q2 Earnings Snapshot - Barchart.com

Viatris (VTRS) Q1 2026 Earnings Call Transcript - Fortune

Viatris Reports Second-Quarter 2026 Financial Results - TradingView

Viatris Q2 preview: Analysts see profits softening amid pressure on generics business (VTRS:NASDAQ) - Seeking Alpha

Viatris (VTRS) Q2 Earnings on the Horizon: Analysts' Insights on Key Performance Measures - Yahoo Finance

Is Wall Street Bullish or Bearish on Viatris Stock? - webull.com

Viatris Inc. declares Quarterly Dividend, Payable on September 16, 2026 - marketscreener.com

Viatris Gears Up to Report Q2 Earnings: What's in the Cards? - Yahoo Finance

Viatris Inc expected to post earnings of 60 cents a shareEarnings Preview - TradingView

Viatris Inc. (VTRS) Stock Analysis: Navigating the Healthcare Giant’s Potential Upside Amid Market Volatility - DirectorsTalk Interviews

Viatris: A Reasonable Valuation (NASDAQ:VTRS) - Seeking Alpha

Viatris (VTRS) Wins FDA Approval For Gwyn Lo Contraceptive Patch - Yahoo Finance

PFE5282055 Bond Profile — Key Metrics - TradingView

Viatris Inc. stock falls Friday, underperforms market - MarketWatch

What Viatris (VTRS)'s FDA Approval of Weekly Gwyn Lo Contraceptive Patch Means For Shareholders - webull.com

Low Growth Viatris Is Due For A Pullback After A Stellar 16-Month Run (NASDAQ:VTRS) - Seeking Alpha

Viatris (VTRS) Q2 Earnings Preview: What's in the Cards? - Yahoo Finance

FDA Approves Viatris’ Gwyn Lo Contraceptive Patch - Pharmaceutical Executive

Viatris Number of Employees 2026 | Employee Count & Headcount Data - Revelio Labs

Generic Pharmaceuticals Stocks Q1 Highlights: Viatris (NASDAQ:VTRS) - Yahoo Finance

Viatris Inc (VTRS) Income Statement - TradingKey

Viatris Inc (VTRS) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey

Viatris Inc. stock rises Monday, outperforms market - MarketWatch

UTHR

$499.73

0.31%

NBIX

$152.72

1.26%

ELAN

$23.67

5.15%

RDY

$12.27

1.21%

ALKS

$49.06

0.79%

Apri su Yahoo | Apri su Google | Aperto in Finviz | Apri in MarketWatch | Aperto a EDGAR | Aperto su Reuters